SG scientists use AI platform to improve effectiveness of Covid-19 drugs against Omicron

Prof Ho and his team used IDentif.AI and explored different combinations and the most precise dosing needed, to amplify the effects of both molnupiravir and Paxlovid against Omicron. — AZMAN GHANI/The Star

SINGAPORE: Researchers in Singapore are hoping artificial intelligence (AI) can help better fight Covid-19 infections, with AI determining the most optimal combination of antiviral drugs and the correct dosing.

A recent study led by Professor Dean Ho, director of the Institute for Digital Medicine at the NUS Yong Loo Lin School of Medicine, has shown some promise.